Technical Analysis for JNCE - Jounce Therapeutics, Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| See historical JNCE trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Doji - Bullish? | Reversal | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Lower Bollinger Band Walk | Weakness | -3.29% | |
| Below Lower BB | Weakness | -3.29% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/08/2019
- Sector: Healthcare
- Industry: Biotechnology
Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company's lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells found in a range of solid tumors. It also developing JTX-4014 for use in future combinations with JTX-2011, as well as for use in combination with other future product candidates. Jounce Therapeutics, Inc. is based in Cambridge, United States.
Biotechnology Life Sciences Biology Natural Sciences Immunology Immunotherapy Solid Tumors Immune System Monoclonal Antibodies
Biotechnology Life Sciences Biology Natural Sciences Immunology Immunotherapy Solid Tumors Immune System Monoclonal Antibodies
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more JNCE news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 11.85 |
| 52 Week Low | 2.66 |
| Average Volume | 212,464 |
| 200-Day Moving Average | 5.4632 |
| 50-Day Moving Average | 5.9778 |
| 20-Day Moving Average | 5.5195 |
| 10-Day Moving Average | 5.326 |
| Average True Range | 0.3802 |
| ADX | 22.95 |
| +DI | 12.4655 |
| -DI | 30.3125 |
| Chandelier Exit (Long, 3 ATRs ) | 4.8594 |
| Chandelier Exit (Short, 3 ATRs ) | 5.7106 |
| Upper Bollinger Band | 6.1982 |
| Lower Bollinger Band | 4.8408 |
| Percent B (%b) | -0.1 |
| BandWidth | 24.592807 |
| MACD Line | -0.2417 |
| MACD Signal Line | -0.1483 |
| MACD Histogram | -0.0935 |
| Fundamentals | Value |
|---|---|
| Market Cap | 151.45 Million |
| Num Shares | 32.2 Million |
| EPS | 0.03 |
| Price-to-Earnings (P/E) Ratio | 157.00 |
| Price-to-Sales | 5.66 |
| Price-to-Book | 2.51 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.33 | ||||
| Resistance 3 (R3) | 5.35 | 5.16 | 5.22 | ||
| Resistance 2 (R2) | 5.16 | 5.01 | 5.15 | 5.19 | |
| Resistance 1 (R1) | 4.94 | 4.91 | 4.85 | 4.92 | 5.15 |
| Pivot Point | 4.75 | 4.75 | 4.71 | 4.74 | 4.75 |
| Support 1 (S1) | 4.53 | 4.60 | 4.44 | 4.51 | 4.27 |
| Support 2 (S2) | 4.34 | 4.50 | 4.33 | 4.23 | |
| Support 3 (S3) | 4.12 | 4.34 | 4.20 | ||
| Support 4 (S4) | 4.10 |
